Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

HOOK

Live52w high -32.8%

Core line items from HOOK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Entity: HOOKIPA PHARMA INC.·Source: SEC EDGAR companyfacts

Metric	Q1 2025 2025-03-31	Annual 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30
Revenue	$2.00M	$43.95M	$42.59M	$37.89M
Operating Income	$-17.87M	$-51.45M	$-30.00M	$-11.35M
Net Income	$-15.43M	$-43.50M	$-18.55M	$-19.09M
EPS (Diluted)	$-1.23	$-3.47	$-1.48	$-0.38
Total Assets	$61.26M	$82.55M	$109.73M	$125.05M
Total Liabilities	$27.18M	$31.33M	$37.93M	$38.98M
Cash & Equivalents	$40.28M	$39.68M	$59.75M	$77.15M
Free Cash Flow OCF − CapEx	$32.00K	$-77.17M	$-56.23M	$-38.69M
Shares Outstanding	12.54M	12.54M	12.54M	12.54M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.

Core line items from HOOK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w high -32.8%

Entity: HOOKIPA PHARMA INC.·Source: SEC EDGAR companyfacts

Metric	Q1 2025 2025-03-31	Annual 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30
Revenue	$2.00M	$43.95M	$42.59M	$37.89M
Operating Income	$-17.87M	$-51.45M	$-30.00M	$-11.35M
Net Income	$-15.43M	$-43.50M	$-18.55M	$-19.09M
EPS (Diluted)	$-1.23	$-3.47	$-1.48	$-0.38
Total Assets	$61.26M	$82.55M	$109.73M	$125.05M
Total Liabilities	$27.18M	$31.33M	$37.93M	$38.98M
Cash & Equivalents	$40.28M	$39.68M	$59.75M	$77.15M
Free Cash Flow OCF − CapEx	$32.00K	$-77.17M	$-56.23M	$-38.69M
Shares Outstanding	12.54M	12.54M	12.54M	12.54M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.